Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Intra-Cellular Therapies Inc (NASDAQ: ITCI) was $71.01 for the day, up 3.21% from the previous closing price of $68.80. In other words, the price has increased by $3.21 from its previous closing price. On the day, 0.75 million shares were traded. ITCI stock price reached its highest trading level at $71.02 during the session, while it also had its lowest trading level at $68.49.
Ratios:
Our analysis of ITCI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.31 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on January 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $83.
On December 11, 2023, TD Cowen started tracking the stock assigning a Outperform rating and target price of $75.
On April 20, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $80.Morgan Stanley initiated its Overweight rating on April 20, 2023, with a $80 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 11 ’24 when Mates Sharon sold 20,565 shares for $65.21 per share. The transaction valued at 1,341,123 led to the insider holds 1,050,309 shares of the business.
Hineline Lawrence J. sold 10,121 shares of ITCI for $667,587 on Mar 11 ’24. The SVP of Finance, CFO now owns 0 shares after completing the transaction at $65.96 per share. On Mar 11 ’24, another insider, Halstead Michael, who serves as the EVP and General Counsel of the company, sold 7,345 shares for $65.97 each. As a result, the insider received 484,537 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITCI now has a Market Capitalization of 7496596992 and an Enterprise Value of 6393275392. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.14 while its Price-to-Book (P/B) ratio in mrq is 11.57. Its current Enterprise Value per Revenue stands at 13.768 whereas that against EBITDA is -40.246.
Stock Price History:
Over the past 52 weeks, ITCI has reached a high of $84.89, while it has fallen to a 52-week low of $45.50. The 50-Day Moving Average of the stock is 2.65%, while the 200-Day Moving Average is calculated to be 13.64%.
Shares Statistics:
ITCI traded an average of 973.21K shares per day over the past three months and 899520 shares per day over the past ten days. A total of 105.57M shares are outstanding, with a floating share count of 102.73M. Insiders hold about 2.69% of the company’s shares, while institutions hold 85.34% stake in the company. Shares short for ITCI as of 1713139200 were 3590941 with a Short Ratio of 3.69, compared to 1710460800 on 3307047. Therefore, it implies a Short% of Shares Outstanding of 3590941 and a Short% of Float of 4.2700000000000005.
